Clinical Trial: NCT06570811
Coenzyme Q10 and Chemotherapeutic Toxicity in Breast Cancer Patients
Status:
COMPLETEDPhase:
Phase 2| Lead Sponsor: | Damanhour University |
| Information Provided By: | Damanhour University |
| Last Update Posted: | 2025-12-26 |
Study Overview
Brief Summary
investigating the potential effect of Coenzyme Q10 in ameliorating and preventing the development of paclitaxel chemotherapeutic toxicity in breast cancer patients
Official Title
Effect of Coenzyme Q10 (COQ10) on Chemotherapeutic Toxicity in Cancer Patients
Conditions
Breast Cancer, Chemotherapeutic Toxicity
Intervention / Treatment
- Drug: Placebo
- Drug: Coenzyme Q10 200mg twice daily
Other Study ID Numbers
- COQ10 Breast Cancer Study
Start Date (Actual)
2024-08-01
Primary Completion Date (Actual)
2025-03-10
Study Completion Date (Actual)
2025-03-30
Enrollment (Actual)
40
Study Type
Interventional
Phase
Phase 2
| Lead Sponsor: | Damanhour University |
| Information Provided By: | Damanhour University |
| Last Update Posted: | 2025-12-26 |
Study Overview
Brief Summary
investigating the potential effect of Coenzyme Q10 in ameliorating and preventing the development of paclitaxel chemotherapeutic toxicity in breast cancer patients
Official Title
Effect of Coenzyme Q10 (COQ10) on Chemotherapeutic Toxicity in Cancer Patients
Conditions
Breast Cancer, Chemotherapeutic Toxicity
Intervention / Treatment
- Drug: Placebo
- Drug: Coenzyme Q10 200mg twice daily
Other Study ID Numbers
- COQ10 Breast Cancer Study
Start Date (Actual)
2024-08-01
Primary Completion Date (Actual)
2025-03-10
Study Completion Date (Actual)
2025-03-30
Enrollment (Actual)
40
Study Type
Interventional
Phase
Phase 2